LED Phototherapy Market to Register a Stout Growth by End 2025

Phototherapy or light therapy is a medical procedure used to treat various skin and other diseases. Light-emitting diode (LED) phototherapy units are developed by incorporating light-emitting diodes bulbs that deliver higher irradiance at cheaper cost, extended life span, less heat production, and provide narrow spectrum wavelength. LED phototherapy is effectively used in the treatment of neonatal jaundice. LEDs are specifically used to emit a narrow wavelength of blue light (dominant wavelength 458 nm) that maximizes the rate of bilirubin breakdown. At this wavelength, light can transform bilirubin into two other compounds -lumirubin and photobilirubin - that can be removed from the body without the involvement of the liver. Lumirubin and photobilirubin chemicals are isomers of bilirubin. They are made of the same atoms with rearranged structures. The radiance level of LED is higher. This helps lower the treatment time. LED phototherapy is cost effective, as the change of bulbs takes place at nearly 20,000 hours compared to 2,000 hours taken by the conventional fluorescent lights. “According to a report published by the International Journal of Pediatric Research (IJOPR) in 2014, LED phototherapy units were more effective in reference to higher rate of fall of bilirubin levels in similar time duration compared to compact fluorescent lamp (CFL) phototherapy units.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41165

Global LED Phototherapy Market: Drivers and Restraints

Rise in number of neonatal jaundice cases has boosted the demand for effective phototherapy treatment. In some cases, neonatal jaundice can lead to severe hyper bilirubinemia like acute bilirubin encephalopathy (ABE) and chronic bilirubin encephalopathy (CBE). The severity of hyperbilirubinemia can be reduced if treated promptly with effective phototherapy. According to the BMJ Publishing Group Limited, the U.K. and Ireland experienced an incidence of severe hyperbilirubinemia (maximum unconjugated serum bilirubin ≥510 micromol/L [29.8 mg/dL]) of 7.1 person per 100,000 people in 2016.

Incidence of severe hyperbilirubinemia creates high demand for LED phototherapy equipment in the treatment of jaundice. Increase in demand for LED technology has encouraged key players to invest in the development of a new device with LED bulb to provide cost-effective products in the market. The U.S. based Natus Medical Incorporated received the FDA clearance for neoBLUE LED Phototherapy System in 2016. The neoBLUE system incorporates optimal blue LED technology for the treatment of newborn jaundice that is more effective in degradation of bilirubin. LED phototherapy is cost effective, consumes less power, and requires minimal maintenance cost. These factors are likely to propel the global LED Phototherapy Market during the forecast period.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=41165

Global LED Phototherapy Market: Key Segments

The global LED phototherapy market can be segmented based on product type, end-user, and region. In terms of product type, the global LED phototherapy market can be divided into overhead, under surface and double surface type LED phototherapy units. These products are designed to meet specific requirements of phototherapy. Based on end user, the global LED phototherapy market can be bifurcated into hospitals and clinics. Approval of LED phototherapy products by the U.S. FDA and CE has increased the availability and access of LED based units among end-users. This is anticipated to boost the hospital segment of the global LED phototherapy market.

In terms of region, the global LED phototherapy market can be segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market in 2016. The region is expected to continue its dominance during the forecast period. The North American Association for Photobiomodulation Therapy (NAALT) aims to promote phototherapy as a valid treatment through public awareness campaigns and organization of conferences for physicians. Asia Pacific is one of the highly lucrative regions of the LED phototherapy market due to rising awareness about the therapy.

Global LED Phototherapy Market: Key Players

Key players operating in the global LED phototherapy market include Natus Medical Incorporated, GE Healthcare, Drägerwerk AG & Co. KGaA, and Phoenix Medical Systems Pvt. Ltd.

View Report -

https://www.transparencymarketresearch.com/led-phototherapy-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.